Xenetic Biosciences, Inc. Uncategorized Contracts & Agreements

35 Contracts & Agreements
Recent Contracts
Category
Company
Industry
Jur. Jurisdiction
Filed
Description of Registrants Securities Registered Pursuant to Section 12 of the Securities Exchange Act of 1934
Xenetic Biosciences, Inc.
Biotechnology
NV
2024
Description of Registrants Securities Registered Pursuant to Section 12 of the Securities Exchange Act of 1934
Xenetic Biosciences, Inc.
Biotechnology
NV
2023
Statement of Work, dated June 30, 2022, between Xenetic Biosciences, Inc. and Catalent Pharma Solutions, LLC
Xenetic Biosciences, Inc.
Biotechnology
2022
Exclusive Sublicense Agreement, dated April 26, 2022, between Xenetic Biosciences, Inc. and CLS Therapeutics LTD
Xenetic Biosciences, Inc.
Biotechnology
DE
2022
At The Market Offering Agreement by and between Xenetic Biosciences, Inc. and H.C. Wainwright & Co., LLC, dated November 19, 2021
Xenetic Biosciences, Inc.
Biotechnology
NY
2021
Form of Letter Agreement by and between Xenetic Biosciences, Inc. and the Holders, dated November 15, 2021
Xenetic Biosciences, Inc.
Biotechnology
2021
Engagement Letter between Xenetic Biosciences, Inc. and H.C. Wainwright & Co., LLC, dated as of July 25, 2021
Xenetic Biosciences, Inc.
Biotechnology
NY
2021
Description of Registrants Securities Registered Pursuant to Section 12 of the Securities Exchange Act of 1934
Xenetic Biosciences, Inc.
Biotechnology
NV
2021
Engagement Letter between Xenetic Biosciences, Inc. and H.C. Wainwright & Co., LLC, dated as of December 9, 2020
Xenetic Biosciences, Inc.
Biotechnology
NY
2020
Form of Letter Agreement re. Appointment of Non Employee, Independent Director of Xenetic Biosciences, Inc
Xenetic Biosciences, Inc.
Biotechnology
MA
2020
Letter Agreement re. Appointment of Non Employee, Independent Director of Xenetic Biosciences, Inc. for Grigory G. Borisenko, effective as of September 26, 2019
Xenetic Biosciences, Inc.
Biotechnology
MA
2020
Description of Registrants Securities Registered Pursuant to Section 12 of the Securities Exchange Act of 1934
Xenetic Biosciences, Inc.
Biotechnology
NV
2020
Consent Agreement
Xenetic Biosciences, Inc.
Biotechnology
NV
2019
CONSENT AGREEMENT
Xenetic Biosciences, Inc.
Biotechnology
NV
2019
Letter Agreement re. Appointment of Non Employee, Independent Director of Xenetic Biosciences, Inc. for James E. Callaway dated October 11, 2017
Xenetic Biosciences, Inc.
Biotechnology
MA
2018
Letter Agreement re. Appointment of Non Employee, Independent Director of Xenetic Biosciences, Inc. for Adam Logal dated October 11, 2017
Xenetic Biosciences, Inc.
Biotechnology
MA
2018
Right to Sublicense Agreement, dated October 27, 2017, by and among Xenetic Biosciences, Inc., Baxalta Incorporated, Baxalta US Inc., and Baxalta GmbH
Xenetic Biosciences, Inc.
Biotechnology
DE
2018
Form of Indemnity Agreement by and between the Registrant and each of its directors and executive officers
Xenetic Biosciences, Inc.
Biotechnology
NV
2017
Directors Letter Agreement
Xenetic Biosciences, Inc.
Biotechnology
MA
2016
Directors Letter Agreement
Xenetic Biosciences, Inc.
Biotechnology
MA
2016
Directors Letter Agreement
Xenetic Biosciences, Inc.
Biotechnology
MA
2016
FORM OF FIRST AMENDMENT TO SUBSIDIARYGUARANTEE
Xenetic Biosciences, Inc.
Biotechnology
2015
FORM OF FIRST AMENDMENT TO SECURITYAGREEMENT
Xenetic Biosciences, Inc.
Biotechnology
2015
FORM OF FIRST AMENDMENT TO REGISTRATION RIGHTSAGREEMENT
Xenetic Biosciences, Inc.
Biotechnology
2015
ASSIGNMENTAND ASSUMPTION AGREEMENT
Xenetic Biosciences, Inc.
Biotechnology
NY
2015
Agreement with Mark Leuchtenberger
Xenetic Biosciences, Inc.
Biotechnology
MA
2014
(1) LIPOXEN PLC (2)LIPOXEN TECHNOLOGIES LTD - and - (2) SERUM INSTITUTE OF INDIA LIMITED ExclusivePatent And Know How Licence and Manufacturing Agreement
Xenetic Biosciences, Inc.
Biotechnology
2014
4 August 2011 AGREEMENT ON CO-DEVELOPMENT AND THE TERMS OF EXCLUSIVE LICENCE between (1) LIPOXENPLC (2) LIPOXEN TECHNOLOGIES LTD - and- (3) SYNBIO LLC
Xenetic Biosciences, Inc.
Biotechnology
2014
AMENDMENT
Xenetic Biosciences, Inc.
Biotechnology
2014
200500453-11412
Xenetic Biosciences, Inc.
Biotechnology
2014
[***]
Xenetic Biosciences, Inc.
Biotechnology
2014
The Crown Estate 16 New Burlington Place London W1S2HX TABLE OF CONTENTS
Xenetic Biosciences, Inc.
Biotechnology
2014
XENETIC BIOSCIENCE, INCORPORATED LEDGEMONT RESEARCH CENTER LEXINGTON, MA
Xenetic Biosciences, Inc.
Biotechnology
2014
Agreement with Dr. Timothy R. Cot
Xenetic Biosciences, Inc.
Biotechnology
MA
2014
Order of the High Court of Justice, Chancery Division, entered January 23, 2014
Xenetic Biosciences, Inc.
Biotechnology
2014